Call for changes to improve COPD care
Posted: 18th November 2026
A new report is recommending actions to improve the lives of people with chronic obstructive pulmonary disease (COPD) in Humber and North Yorkshire.
It follows a collaboration between Humber and North Yorkshire ICB, Hull University Teaching Hospitals NHS Trust, Health Innovation Yorkshire & Humber and Sanofi, targeting an area with the fifth highest prevalence of COPD in England, with 2.5 per cent of the population or 45,330 people diagnosed – and an estimated 7,253 undiagnosed.
In 2024-25, emergency admissions reached 4,895, an increase of 28 per cent over three years, at a cost of £11.98m.
Evidence shows that the greatest burden falls on deprived communities.
Now, a report from the Humber and North Yorkshire COPD Pathway Review has endorsed a model of care that prioritises earlier intervention, joined-up care and support that prevents crisis rather than responds to it.
Dr David Linden, Respiratory Workstream Lead at Health Innovation Yorkshire & Humber said: “This was an in-depth study of the evidence available about the prevalence of COPD, triangulated with structured interviews with 34 frontline clinicians and managers; and direct testimony from patients.
“What it found was a significant number of undiagnosed COPD patients; opportunities to expand the respiratory workforce; plus health inequalities which mean that those in deprived areas were more at risk.
“The collaborative project has now produced a set of recommendations for the local health system which aim to improve diagnosis, prevent unnecessary exacerbations of COPD leading to emergency admissions; and increase the emotional wellbeing of patients.”
Professor Mike Crooks, Respiratory Consultant and Clinical Lead for the Humber and North Yorkshire Respiratory Clinical Network, said: “Our approach was to comprehensively explore both clinical and patient perspectives in order to identify opportunities to improve how we deliver care for those with COPD in our region.
“We identified areas that both patients and clinicians recognised as areas of focus, such as diagnosis and staffing, and also clearly identified the profound emotional and social impact of COPD, including anxiety, isolation and a sense of loss of dignity, which was consistently and powerfully described by patients. It is therefore essential that we as clinicians recognise both the physical and emotional impacts of COPD.
“Listening to multiple voices, rather than relying on a single perspective, produced a robust, shared evidence base for change.”
The review also applied analytical problem-solving to operational data: Yorkshire Ambulance Service records identified 48 high-intensity users generating over 1,000 ambulance calls in two years, enabling a precise, data-defined cohort for proactive case management rather than a generic high-risk category.
Sanofi Project Manager Lisa-Marie Dawkins said: “This partnership showed how pharma and the NHS can jointly address systemic, population-level challenges with shared accountability, transparency and a sustained focus on reducing inequality and improving patient care.
“Not only have we produced a set of actions which have the potential to improve care, we have created a framework which other areas can adopt, to meet the needs of their population.”
Commissioned by NHS Humber Health Partnership and presented to Humber and North Yorkshire ICB, the report sets out nine implementation priorities, each aligned with national policy including the NHS Long Term Plan, the Neighbourhood Health framework and the 10 Year Health Plan.
Recommendations include ICB-level workforce planning for recruitment and retention, a primary care training programme with neighbourhood spirometry hubs, shared IT infrastructure for cross-sector patient records, and population risk stratification to direct resources where need is greatest.
These recommendations are now helping to shape the region’s neighbourhood models of care, with many already being translated into action through local implementation.
To receive a copy of the report, email: David.Linden@healthinnovationyh.com